Clinical Trial Update: Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase 2 study evaluating an anti-TNF therapy for Takayasu arteritis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Takayasu Arteritis

Drugs mentioned

• Anti-TNF therapy

Snippet

Sponsor: Seoul National University Hospital | Conditions: Takayasu's Arteritis | Phase 2 | Status: UNKNOWN